Eli Lilly and Company (LLY) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Get detailed Eli Lilly and Company (LLY) stock forecast for 2025, monthly, along with long-term LLY price prediction from 2025 to 2050. Look at historical stock performance, analyst recommendations (Buy, Sell, or Hold), and the latest Eli Lilly and Company headlines.
1 Month Prediction
$1735.67 [105.58%]
3 Month Prediction
$1797.59 [112.92%]
6 Month Prediction
$1989.55 [135.65%]
1 Year Prediction
$2083.94 [146.83%]
3 Year Prediction
$2777.78 [229.02%]
5 Year Prediction
$3445.07 [308.05%]
About Eli Lilly and Company
Eli Lilly and Company, commonly known as Lilly, is an American multinational pharmaceutical firm headquartered in Indianapolis, Indiana. The company was Founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist and Civil War veteran.
Lilly operates in around 110 countries and employs around 42,978 people, with most of them engaged in R & D. Also, The company's products are marketed in about 125 countries, and it conducts clinical research in over 55 countries.
Lilly makes its product around diabetes, oncology, immunology, and neuroscience. Its most famous medications are Mounjaro and Zepbound for diabetes and weight management, and Verzenio for breast cancer.
Eli Lilly and Company (LLY) Historical Performance
IPO Date
Eli Lilly and Company (NYSE:LLY) went public on 25 March, 2013.
Change
Since inception, LLY has increased by 56,808.60%. In the last 5 years, LLY has risen from $130.69 to $844.27, a massive 546.0% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $957.10 and a low of $124.09.
52 Week Range
$711.4
$972.53
The current price $844.27 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
LLY Stock Price History
Based on LLY stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the LLY stock has risen from $118.22 - $161.42 to $811.08 - $844.27, which is up 662.45%. Currently, the stock follows upward trend.
Here, we have calculated stock range of LLY, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $118.22 - $161.42 | $139.38 | 28.4 | 1 Year Change |
| 2021 | $175.47 - $268.08 | $218.71 | 101.47 | 2 Year Change |
| 2022 | $238.16 - $364.06 | $306.71 | 182.54 | 3 Year Change |
| 2023 | $306.18 - $586.12 | $458.99 | 322.82 | 4 Year Change |
| 2024 | $641.42 - $957.1 | $808.23 | 644.53 | 5 Year Change |
| 2025 | $811.08 - $844.27 | $827.68 | 662.45 | 6 Year Change |
LLY Price Performance
6-Month Performance
LLY stock dropped by 4.55% in the last six months.
1-Year Performance
The stock has trended upwards by 9.04% in the past year.
3-Year Performance
In the last 3 years, the stock has soared by 202.50%.
5-Year Performance
In the last 5 years, the stock has gone up by 546.00%.
According to Eli Lilly and Company's historical data, below graph gives us the exact picture of how the LLY stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 5 years and a decline in 0 year.
2020
31.04% ↑
2021
66.08% ↑
2022
34.26% ↑
2023
60.91% ↑
2024
33.30% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Eli Lilly and Company (LLY) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $11.44 B (Q3)
Revenue for Q3 ending 30th September, 2024 increased 1.21% compared to Q2 ending 30th June, 2024.
Annual Revenue: $40.86 B (1Y)
Revenue for trailing 12 months increased 19.75% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $24.54 billion to $40.86 billion, a 66.52% change.
Market Capitalization
Eli Lilly and Company has a market capitalization of $759.27B, which places LLY in the mega-cap category.
Fundamental Analysis
EPS: $1.08 (Q3), $5.83 (1Y)
EPS decreased 67.17% since last quarter, and decreased 11.34% since last year.
Net Income: $970.30 M (Q3), $5.24 B (1Y)
Net Income decreased 67.30% since last quarter, and decreased 16.08% since last year.
Free Cash Flow: $-458.90 M (Q3), $-3.15 B (1Y)
Free Cash Flow decreased 823.82% since last quarter, and decreased 168.52% since last year.
Net Profit Margin: 8.48% (Q3), 12.82% (1Y)
Net Profit Margin decreased 67.69% since last quarter, and decreased 29.92% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for LLY stock. These indicators help you understand Eli Lilly and Company's financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for LLY stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $818.80 |
| SMA50 | $798.74 |
| SMA200 | $844.74 |
| RSI | 61.73 |
| Beta | 0.41 |
SMA20 < Current Price
This signals LLY stock is in short-term bullish momentum.
SMA50 < Current Price
This signals LLY stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals LLY stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for LLY stock is Bullish. Out of all indicators, 4 indicates bullish signals, 2 signals bearish trends and 3 gives neutral trends. The LLY stock forecast was last updated on 16 February, 2025.
Eli Lilly and Company (LLY) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $1918.98 by the end of 2025, and can reach around $1772.66 to $2086.75 in 2026. And, the long-term forecast suggests that the stock may further jump to $2690.78 - $2738.52 in 2028, and $3488.85 - $4126.67 by 2031. So, the LLY stock shows a strong upward trend in the next several years.
Short-term LLY Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $1735.67 | 105.58% |
| 2025-04 | $1746.22 | 106.83% |
| 2025-05 | $1797.59 | 112.92% |
| 2025-06 | $1898.91 | 124.92% |
| 2025-07 | $1814.35 | 114.9% |
| 2025-08 | $1989.55 | 135.65% |
| 2025-09 | $1882.91 | 123.02% |
| 2025-10 | $1895.80 | 124.55% |
| 2025-11 | $1930.44 | 128.65% |
| 2025-12 | $1918.98 | 127.29% |
In 2025, the LLY stock price is expected to fluctuate between $1735.67 and $1989.55. According to the monthly forecast, the stock could rise to $1918.98 by December 2024. If compared to the LLY's current price, the stock could gain 127.29% by the end of this year.
Long-term LLY Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $1772.66 | $1964.11 | $2086.75 | 147.17% |
| 2027 | $2301.98 | $2447.84 | $2803.16 | 232.02% |
| 2028 | $2690.78 | $2822.40 | $2738.52 | 224.37% |
| 2029 | $3229.96 | $2518.87 | $2473.37 | 192.96% |
| 2030 | $2824.93 | $3649.05 | $3517.45 | 316.63% |
| 2031 | $3488.85 | $2885.23 | $4126.67 | 388.79% |
| 2032 | $3945.20 | $3555.73 | $4274.27 | 406.27% |
| 2033 | $4662.80 | $4382.48 | $4977.06 | 489.51% |
| 2034 | $4379.05 | $4721.44 | $4749.52 | 462.56% |
| 2035 | $4593.23 | $5271.98 | $4777.72 | 465.9% |
| 2036 | $6021.46 | $4883.39 | $5081.26 | 501.85% |
| 2037 | $5386.56 | $5728.29 | $5760.54 | 582.31% |
| 2038 | $4946.84 | $6408.60 | $6066.14 | 618.51% |
| 2039 | $5339.86 | $5489.29 | $5901.11 | 598.96% |
| 2040 | $6519.22 | $5828.95 | $6398.17 | 657.83% |
| 2041 | $6674.81 | $6845.47 | $7195.37 | 752.26% |
| 2042 | $6933.27 | $7145.18 | $7708.88 | 813.08% |
| 2043 | $7492.10 | $7096.76 | $6851.13 | 711.49% |
| 2044 | $9217.67 | $8107.98 | $7676.63 | 809.26% |
| 2045 | $9171.95 | $9205.26 | $9297.23 | 1001.22% |
| 2046 | $9309.79 | $8628.21 | $9037.97 | 970.51% |
| 2047 | $9225.94 | $9294.63 | $8104.44 | 859.93% |
| 2048 | $7543.76 | $9647.43 | $9123.13 | 980.59% |
| 2049 | $10262.17 | $9220.64 | $9454.12 | 1019.8% |
| 2050 | $9583.53 | $10445.24 | $10648.02 | 1161.21% |
| 2051 | $9329.43 | $11152.49 | $9798.79 | 1060.62% |
Eli Lilly and Company (LLY) Stock Price Prediction & Forecast 2025
At the start of 2025, the LLY stock was at $811.08. Today, it is trading at $844.27, which is 4.09% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $1918.98 by December 2025 with a 127.29% change.
Eli Lilly and Company (LLY) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the LLY stock. During this period, the LLY's price is forecasted to shift from $1772.66 to $3517.45, which is 98.43% gain.
In 2026, the stock would possibly open at $1772.66, escalates to $1964.11 by mid-year, and wraps up at $2086.75, reflecting a 147.17% increase from today's price. Further moving to 2030, the stock can kick off the year at $2824.93, soar to $3649.05 by mid-year, and finish at $3517.45, which is 316.63% change from current price.
Eli Lilly and Company (LLY) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $3488.85 to $6398.17, which is up 388.79%
In 2031, we can expect LLY to fluctuate between $3488.85 and $4126.67, a shift indicating a 388.79% gain by year-end compared to current price. And Until 2040, LLY can likely vary from $6398.17 to $6519.22. By the end of 2040, the stock could record a 657.83% rise from today's stock price.
Eli Lilly and Company (LLY) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the LLY stock can see an an upturn from $6674.81 to $10648.02 in this period. In 2041, the stock can experience a high of $6845.47 by mid-year, closing the year at $7195.37. This results in a 710.82% increase from today.
Moving towards the end of 2050, LLY is projected to open the year at $9583.53. The stock may peak to $10445.24 during mid-year and finish the year at $10648.02. Compared to the stock's current price, this translates to an overall gain of 1161.21% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
LLY Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | - | $59.28 | -0.56% ▼ | $58.39 ▲ |
| MRK | Merck & Co., Inc. | - | $87.87 | -3.93% ▼ | $146.41 ▲ |
| ABBV | AbbVie Inc. | - | $210.75 | 0.82% ▲ | $81.29 ▲ |
| NVO | Novo Nordisk A/S | - | $73.60 | -18.81% ▼ | $247.89 ▲ |
| JNJ | Johnson & Johnson | - | $163.63 | -0.05% ▼ | $80.87 ▲ |
Last updated Feb 16 at 9 PM
LLY : Buy, Sell Or Hold?
Analyst Ratings
Based on 27 analysts, 5 rated as a strong buy, 15 recommended a buy, 6 suggested a hold, 0 advised a sell, and 1 indicated a strong sell.Three months ago, out of 27 analysts, 6 analysts gave a strong buy rating, 16 a buy rating, 5 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for LLY stock is Buy.Expert Analysis
According to LLY short-term and long-term forecast, Eli Lilly and Company shares are projected to go up by 1161.21%, and reach a value of $10648.02 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 71.42857142857143, which signals Greed. Also, LLY has recorded 13/30 green days, which reflects a 59.09090909090909% positivity rate with a price volatility of 0.02%.
Plus, Price-to-Earnings (P/E) ratio of 71.91397 suggests that LLY stock is overvalued. So, Based on LLY prediction and analysis, it may be the best time to hold LLY stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "LLY” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.